Metabolic effects of antihypertensive treatment should not be overstatedBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7075.223 (Published 18 January 1997) Cite this as: BMJ 1997;314:223
- Peter H Winocour, Consultant physiciana
- a Medical Directorate, Queen Elizabeth II Hospital, Welwyn Garden City AL7 4HQ
Editor–Ola Samuelsson and colleagues conclude that neither evolving diabetes nor increasing triglyceridaemia during antihypertensive treatment has a significant impact on coronary heart disease.1 Their method of analysis leaves much room for doubt.
Firstly, their definition of diabetes mellitus does not agree with that in the stated reference,2 in which fasting whole blood glucose concentrations of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial